Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians.

Citrome, Leslie; Belcher, Emily; Stacy, Sylvie; Suett, Mark; Mychaskiw, Marko; Salinas, Gregory D

Citrome, Leslie; Belcher, Emily; Stacy, Sylvie; Suett, Mark; Mychaskiw, Marko; Salinas, Gregory D.

Afiliación

Citrome L; Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA.
Belcher E; Department of Research and Assessment, CE Outcomes, LLC, Birmingham, AL, USA.
Stacy S; Department of Research and Assessment, CE Outcomes, LLC, Birmingham, AL, USA.
Suett M; Teva UK Limited, Global Medical Affairs, Harlow, UK.
Mychaskiw M; Teva Branded Pharmaceutical Products R&D, Inc., Global Health Economics and Outcomes Research, West Chester, PA, USA.
Salinas GD; Department of Research and Assessment, CE Outcomes, LLC, Birmingham, AL, USA.

Neuropsychiatr Dis Treat ; 18: 111-123, 2022.

Article en En | MEDLINE | ID: mdl-35115779

Palabras clave

barriers; depot; injectable; long-acting; long-acting antipsychotic medication; unmet needs

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Qualitative_research Aspecto: Patient_preference Idioma: En Revista: Neuropsychiatr Dis Treat Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google